Exact Sciences Corp
(NAS:EXAS)
$
54.29
-0.43 (-0.79%)
Market Cap: 10.05 Bil
Enterprise Value: 11.88 Bil
PE Ratio: 0
PB Ratio: 3.13
GF Score: 80/100 Exact Sciences Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 06:10PM GMT
Release Date Price:
$119.2
(+4.53%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Good afternoon, everyone. I'm Matt Sykes, senior research analyst for life sciences tools and diagnostics at Goldman Sachs. I have the pleasure of welcoming Exact Sciences management to our conference today. Today, we have Jeff Elliott, Executive Vice President, Chief Financial and Operating Officer; and Jake Orville, the General Manager Pipeline. Jeff, Jake, thanks so much for joining us.
Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO
Thanks, Matt. Great to be here.
Questions & Answers
Matthew Carlisle Sykes;Jeffrey T. Elliott
Goldman Sachs Group, Inc., Research Division - Research Analyst;Exact Sciences
Great. Maybe we'll just start out, and I'll kind of let you set the stage initially and maybe talk about some of the recent trends you've seen, your performance in the first quarter and some of your key thoughts and drivers for the balance of this year.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot